Short Interest in CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) Drops By 90.7%

CNBX Pharmaceuticals Inc. (OTCMKTS:CNBX) saw a large decrease in short interest in April. As of April 30th, there was short interest totaling 3,630 shares, a decrease of 90.7% from the April 15th total of 38,959 shares. Based on an average daily trading volume, of 264,647,257 shares, the days-to-cover ratio is currently 0.0 days.

CNBX Pharmaceuticals Stock Performance

CNBX Pharmaceuticals stock remained flat at $0.00 during mid-day trading on Monday. 8,543,658 shares of the company’s stock were exchanged, compared to its average volume of 39,620,926. CNBX Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $0.01.

CNBX Pharmaceuticals Company Profile

CNBX Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the research and development of synthetic cannabinoid-based drug candidates. The company’s proprietary platform applies medicinal chemistry techniques to design novel small-molecule analogs of naturally occurring cannabinoids, aiming to improve efficacy and safety compared with existing therapies. Its pipeline includes multiple preclinical compounds targeting neuropathic and chronic pain, with a goal of advancing these candidates through IND-enabling studies.

Headquartered in Costa Mesa, California, CNBX Pharmaceuticals collaborates with contract research organizations and academic partners to conduct pharmacology and toxicology studies as well as scale up manufacturing processes.